Chugai Pharmaceutical: Notice Concerning Completion of Disposal of Own Shares as a Stock Remuneration System with Transfer Restrictions
Chugai Pharmaceutical: Supplementary material on consolidated financial results for the 1st quarter of fiscal year 2024. 12 (IFRS)
Chugai Pharmaceutical: Consolidated Financial Statements (IFRS) (non-audited) (1st quarter of fiscal year 2024)
Chugai Pharmaceutical: F. Hoffman La Roche announces sales for the first quarter of 2024
Chugai Pharmaceutical: Sales results for F Hoffman La Roche for the first quarter of 2024
Chugai Pharmaceutical: Corporate Governance Report
Chugai Pharmaceutical: Matters relating to controlling shareholders, etc.
Chugai Pharmaceutical: Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan
Chugai Pharmaceutical: Independent Officer Notification Form
Chugai Pharmaceutical: Eli Lilly & Co. Discloses Form 10-K containing Orforgripron-related information
Chugai Pharmaceutical: Form 10-K disclosure including information related to orforglipron by Eli Lilly & Co.
Chugai Pharmaceutical: Notice Regarding the Difference of Individual Financial Results as Compared to Actual Results for the Previous Year
Chugai Pharmaceutical: Supplementary Materials for Consolidated Financial Results for Fiscal Year 2023. 12 (IFRS)
Chugai Pharmaceutical: CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited)(for the fiscal year 2023)
Chugai Pharmaceutical: Notice regarding partial changes to the Articles of Incorporation
Chugai Pharmaceutical: Notice of Partial Amendment to the Articles of Incorporation
Chugai Pharmaceutical: F. Hoffmann-La Roche Announces Financial Results for Fiscal 2023
Chugai Pharmaceutical: Corporate Governance Report
Chugai Pharmaceutical: Supplementary Materials for Consolidated Financial Results for the 3rd Quarter of Fiscal Year 2023. 12 (IFRS)
Chugai Pharmaceutical: CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited)(for the third quarter of the fiscal year 2023)
No Data